Xanthelasma palpebrarum responding to interleukin-1 blockade
| Authors | |
|---|---|
| Year of publication | 2014 |
| Type | Article in Periodical |
| Magazine / Source | Internal medicine journal |
| MU Faculty or unit | |
| Citation | |
| Doi | http://dx.doi.org/10.1111/imj.12441 |
| Field | Oncology and hematology |
| Keywords | xanthelasma palpebrarum; Erdheim–Chester disease; anakinra |
| Description | Darstein et al. presented an interesting case of a 45-yearold man diagnosed with Erdheim–Chester disease (ECD), a rare non-Langerhans cell histiocytosis characterised by proliferation and accumulation of lipid laden foamy histiocytes. Subsequently, the patient was successfully treated with combination of anakinra (interleukin-1 receptor antagonist) and glucocorticoids.1 We draw readers’ attention to xanthelasma palpebrarum as a common manifestation of ECD. |